Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 117,319 | 273,965 | 139,575 | 195,110 | 75,821 |
| General And Administrative Expense | 117,319 | 273,965 | 133,408 | 193,506 | 75,321 |
| Research And Development | -- | -- | -- | 51,973 | 12,000 |
| Operating Expense | 117,319 | 273,965 | 139,575 | 195,110 | 75,821 |
| Operating Income | -117,319 | -273,965 | -139,575 | -195,110 | -75,821 |
| EBIT | -117,319 | -273,965 | -139,575 | -195,110 | -75,821 |
| Interest Income | 0.00 | 738.00 | 0.00 | 0.00 | 1,190 |
| Interest Income Non Operating | 0.00 | 738.00 | 0.00 | 0.00 | 1,190 |
| Net Interest Income | 0.00 | 738.00 | 0.00 | 0.00 | 1,190 |
| Other Income Expense | 1,000 | 500.00 | -- | 500.00 | 270.00 |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 270.00 |
| Gain On Sale Of Security | 1,000 | 500.00 | -- | 500.00 | -- |
| Pretax Income | -116,319 | -272,727 | -139,575 | -194,610 | -74,631 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| Net Income From Continuing Operation Net Minority Interest | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| Net Income Including Noncontrolling Interests | -116,319 | -272,727 | -139,575 | -194,610 | -74,631 |
| Net Income Common Stockholders | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| Net Income | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| EBITDA | -117,319 | -273,965 | -139,575 | -195,110 | -75,821 |
| Normalized EBITDA | -118,319 | -274,465 | -139,575 | -195,610 | -75,821 |
| Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Basic Average Shares | 46.2M | 46.2M | 39.8M | 35.3M | 30.0M |
| Diluted Average Shares | 46.2M | 46.2M | 39.8M | 35.3M | 30.0M |
| Total Unusual Items | 1,000 | 500.00 | -- | 500.00 | -- |
| Total Unusual Items Excluding Goodwill | 1,000 | 500.00 | -- | 500.00 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -117,319 | -273,227 | -139,575 | -194,610 | -74,631 |
| Diluted NI Availto Com Stockholders | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| Insurance And Claims | 1,875 | 1,875 | 2,055 | 1,875 | 1,875 |
| Net Income Continuous Operations | -116,319 | -272,727 | -139,575 | -194,610 | -74,631 |
| Net Non Operating Interest Income Expense | 0.00 | 738.00 | 0.00 | 0.00 | 1,190 |
| Other Gand A | 113,194 | 122,840 | 129,103 | 189,381 | 55,784 |
| Rent And Landing Fees | 2,250 | 2,250 | 2,250 | 2,250 | 2,250 |
| Rent Expense Supplemental | 2,250 | 2,250 | 2,250 | 2,250 | 2,250 |
| Salaries And Wages | 0.00 | 147,000 | 0.00 | 0.00 | 15,412 |
| Selling And Marketing Expense | 0.00 | 0.00 | 6,167 | 1,604 | 500.00 |
| Total Expenses | 117,319 | 273,965 | 139,575 | 195,110 | 75,821 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 164,130 | 331,023 | 82,386 | 425,106 | 140,581 |
| Cash Cash Equivalents And Short Term Investments | 168,630 | 334,523 | 87,386 | 430,106 | 145,081 |
| Cash Financial | 164,130 | 331,023 | 82,386 | 425,106 | 140,581 |
| Other Short Term Investments | 4,500 | 3,500 | 5,000 | 5,000 | 4,500 |
| Receivables | 16,028 | 9,565 | 42,827 | 38,936 | 15,718 |
| Prepaid Assets | 31,101 | 8,805 | 139,481 | 37,172 | 34,537 |
| Current Assets | 215,759 | 352,893 | 269,694 | 506,214 | 195,336 |
| Net PPE | 3.5M | 3.4M | 3.4M | 3.0M | 2.7M |
| Other Non Current Assets | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 |
| Total Non Current Assets | 3.5M | 3.5M | 3.4M | 3.0M | 2.7M |
| Total Assets | 3.7M | 3.8M | 3.7M | 3.5M | 2.9M |
| Accounts Payable | 45,475 | 17,443 | 100,944 | 99,224 | 171,957 |
| Payables | 54,595 | 28,043 | 127,963 | 112,748 | 177,787 |
| Payables And Accrued Expenses | 54,595 | 28,043 | 127,963 | 112,748 | 177,787 |
| Other Current Liabilities | -- | 1.00 | -- | -- | -- |
| Current Liabilities | 54,595 | 28,044 | 127,963 | 112,748 | 227,787 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 54,595 | 28,044 | 127,964 | 112,748 | 227,787 |
| Common Stock | 5.7M | 5.7M | 5.2M | 5.0M | 4.1M |
| Capital Stock | 5.7M | 5.7M | 5.2M | 5.0M | 4.1M |
| Retained Earnings | -3.1M | -3.0M | -2.6M | -2.5M | -2.3M |
| Gains Losses Not Affecting Retained Earnings | 1.1M | 1.1M | 887,834 | 887,834 | 800,838 |
| Common Stock Equity | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Stockholders Equity | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Total Equity Gross Minority Interest | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Total Capitalization | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Net Tangible Assets | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Tangible Book Value | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Working Capital | 161,164 | 324,849 | 141,731 | 393,466 | -32,451 |
| Invested Capital | 3.7M | 3.8M | 3.5M | 3.4M | 2.7M |
| Share Issued | 46.2M | 46.2M | 40.9M | 38.4M | 29.8M |
| Ordinary Shares Number | 46.2M | 46.2M | 40.9M | 38.4M | 29.8M |
| Current Deferred Liabilities | -- | -- | -- | -- | 50,000 |
| Dueto Related Parties Current | 9,120 | 10,600 | 27,019 | 13,524 | 5,830 |
| Taxes Receivable | 16,028 | 9,565 | 42,827 | 38,936 | 15,718 |
| Line Item | Q4 2025Nov 30, 2025 | Q3 2025Aug 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -134,181 | -68,105 | -235,018 | -175,678 | -60,132 |
| Cash Flow From Continuing Operating Activities | -141,322 | -60,964 | -235,018 | -175,651 | -60,159 |
| Stock Based Compensation | 0.00 | 147,000 | 0.00 | 0.00 | 15,412 |
| Change In Working Capital | -24,003 | 65,263 | -95,443 | 18,959 | -940.00 |
| Change In Receivables | -13,595 | 3,566 | -3,891 | -22,110 | -5,116 |
| Change In Payables And Accrued Expense | 11,888 | 2,080 | 10,757 | 57,824 | 9,436 |
| Change In Payable | 11,888 | 2,080 | 10,757 | 57,824 | 9,436 |
| Other Non Cash Items | -- | -7,141 | -- | -- | 27.00 |
| Capital Expenditure | -32,712 | -28,895 | -107,702 | -411,048 | -20,694 |
| Purchase Of PPE | -32,712 | -28,895 | -107,702 | -411,048 | -20,694 |
| Net PPE Purchase And Sale | -32,712 | -28,895 | -107,702 | -411,048 | -20,694 |
| Investing Cash Flow | 35,393 | -97,000 | -107,702 | -411,048 | -20,694 |
| Cash Flow From Continuing Investing Activities | -32,712 | -28,895 | -107,702 | -411,048 | -20,694 |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 921,250 | 36,000 |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 921,250 | 36,000 |
| Financing Cash Flow | 0.00 | 0.00 | 0.00 | 871,250 | 86,000 |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 0.00 | 871,250 | 86,000 |
| Changes In Cash | -166,893 | -97,000 | -342,720 | 284,525 | 5,173 |
| Beginning Cash Position | 331,023 | 428,023 | 425,106 | 140,581 | 135,408 |
| End Cash Position | 164,130 | 331,023 | 82,386 | 425,106 | 140,581 |
| Free Cash Flow | -166,893 | -97,000 | -342,720 | -586,726 | -80,826 |
| Change In Account Payable | 10,368 | 1,398 | -2,738 | 63,130 | 6,936 |
| Change In Prepaid Assets | -22,296 | 59,617 | -102,309 | -16,755 | -5,260 |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 921,250 | 36,000 |
| Net Income From Continuing Operations | -116,319 | -272,727 | -139,575 | -194,110 | -74,631 |
| Net Other Financing Charges | -- | -- | -- | -- | 50,000 |
| Net Other Investing Changes | -- | -68,105 | -- | -20,010 | 20,000 |
| Unrealized Gain Loss On Investment Securities | -1,000 | -500.00 | 0.00 | -500.00 | 0.00 |